These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22867554)

  • 21. Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
    Sinha S; Chiu DY; Peebles G; Kolakkat S; Lamerton E; Fenwick S; Kalra PA
    J Ren Care; 2009 Jun; 35(2):67-73. PubMed ID: 19432851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerated total dose infusion of low molecular weight iron dextran is safe and efficacious in chronic kidney disease patients.
    Sinha S; Chiu D; Peebles G; Swoboda P; Kolakkat S; Lamerton E; Fenwick S; Bhandari S; Kalra PA
    QJM; 2011 Mar; 104(3):221-30. PubMed ID: 20956457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of pica (ingestion of non-food substances) accompanying iron deficiency anemia after gastric bypass surgery.
    Kushner RF; Shanta Retelny V
    Obes Surg; 2005; 15(10):1491-5. PubMed ID: 16354533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A trial of two iron-dextran infusion regimens in chronic hemodialysis patients.
    Agarwal R; Davis JL; Hamburger RJ
    Clin Nephrol; 2000 Aug; 54(2):105-11. PubMed ID: 10968685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Status of Iron Metabolism 10 Years After Roux-En-Y Gastric Bypass.
    Monaco-Ferreira DV; Leandro-Merhi VA
    Obes Surg; 2017 Aug; 27(8):1993-1999. PubMed ID: 28197864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The practice of pancreatic resection after Roux-en-Y gastric bypass.
    Barbour JR; Thomas BN; Morgan KA; Byrne TK; Adams DB
    Am Surg; 2008 Aug; 74(8):729-34. PubMed ID: 18705575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease.
    Wikström B; Bhandari S; Barany P; Kalra PA; Ladefoged S; Wilske J; Thomsen LL
    J Nephrol; 2011; 24(5):589-96. PubMed ID: 21240875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patients.
    Auerbach M; Winchester J; Wahab A; Richards K; McGinley M; Hall F; Anderson J; Briefel G
    Am J Kidney Dis; 1998 Jan; 31(1):81-6. PubMed ID: 9428456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laparoscopic Roux-en-Y gastric bypass: minimally invasive bariatric surgery for the superobese in the community hospital setting.
    Moose D; Lourie D; Powell W; Pehrsson B; Martin D; LaMar T; Alexander J
    Am Surg; 2003 Nov; 69(11):930-2. PubMed ID: 14627250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen malabsorption after Roux-en-Y gastric bypass surgery: case series and review of the literature.
    Wills SM; Zekman R; Bestul D; Kuwajerwala N; Decker D
    Pharmacotherapy; 2010 Feb; 30(2):217. PubMed ID: 20099995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of nutrient deficiencies in bariatric patients.
    Toh SY; Zarshenas N; Jorgensen J
    Nutrition; 2009; 25(11-12):1150-6. PubMed ID: 19487104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous iron dextran treatment in predialysis patients with chronic renal failure.
    Dahdah K; Patrie JT; Bolton WK
    Am J Kidney Dis; 2000 Oct; 36(4):775-82. PubMed ID: 11007680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron absorption and therapy after gastric bypass.
    Rhode BM; Shustik C; Christou NV; MacLean LD
    Obes Surg; 1999 Feb; 9(1):17-21. PubMed ID: 10065575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of iron, folate, and vitamin B12 deficiency anemia after laparoscopic Roux-en-Y gastric bypass.
    Vargas-Ruiz AG; Hernández-Rivera G; Herrera MF
    Obes Surg; 2008 Mar; 18(3):288-93. PubMed ID: 18214631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laparoscopic Roux-en-Y gastric bypass in the "megaobese".
    Kreitz K; Rovito PF
    Arch Surg; 2003 Jul; 138(7):707-9; discussion 710. PubMed ID: 12860749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
    Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
    Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaemia and related nutrient deficiencies after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis.
    Weng TC; Chang CH; Dong YH; Chang YC; Chuang LM
    BMJ Open; 2015 Jul; 5(7):e006964. PubMed ID: 26185175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of total dose infusion of iron dextran in iron deficiency anaemia.
    Reddy CM; Kathula SK; Ali SA; Bekal R; Walsh M
    Int J Clin Pract; 2008 Mar; 62(3):413-5. PubMed ID: 18005041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergency room visits after laparoscopic Roux-en-Y gastric bypass for morbid obesity.
    Cho M; Kaidar-Person O; Szomstein S; Rosenthal RJ
    Surg Obes Relat Dis; 2008; 4(2):104-9. PubMed ID: 17974500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety of intravenous iron dextran (Dexferrum) during hemodialysis in patients with end stage renal disease.
    Hood SA; O'Brien M; Higgins R
    Nephrol Nurs J; 2000 Feb; 27(1):41-2. PubMed ID: 10852689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.